January 12, 2022 -- The BioInnovation Institute (BII) has been awarded a grant from the Bill & Melinda Gates Foundation to accelerate efforts to discover translational world-class research that identifies new technologies and solutions that can improve the health of women and girls around the world, including low-income countries.
The grant supports BII's vision to strengthen the European ecosystem for research and startups that address unmet medical needs within women's health and family planning. The grant will allow for sufficient resource allocation to drive the initiative, and BII will contribute by applying its expertise in project scouting in combination with a strong scientific and investor network.
As part of this joint initiative, BII will conduct a thorough analysis and identify leading research and startup opportunities for women's health, with the potential for future funding from BII and partners. BII will also undertake community building and awareness, creating activities with selected key partners within the ecosystem.
BII is a nonprofit foundation known for incubating and advancing world-class life science research. The organization already focuses on women's health and has an existing portfolio of promising women's health and family planning projects. However, the new initiative, with support from the Bill & Melinda Gates Foundation, paves the way for BII to accelerate existing efforts to discover translational world-class research that can improve women's health.